GOSS Simply Wall St. 2 days ago How The Gossamer Bio (GOSS) Story Is Shifting After PROSERA And New Street Valuations
GOSS Benzinga 4 days ago Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1 📊 AI Sentiment Positive 7/10
GOSS Zacks 6 days ago Earnings Preview: Gossamer Bio (GOSS) Q4 Earnings Expected to Decline 📉 AI Sentiment Negative 3/10
GOSS MT Newswires 6 days ago Oppenheimer Adjusts Price Target on Gossamer Bio to $3 From $12, Maintains Outperform Rating